complications in patients with HIV1 infection

From Aaushi
Jump to navigation Jump to search

Complications

* opportunistic infection with Pneumocystis jirovecii is the most common cause of death in patients with AIDS[1]

* Mycobacterium avium & CMV generally occur in HIV1 patients with CD4 counts < 50/uL[1]

Notes

More general terms

More specific terms

Additional terms

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 Medical Knowledge Self Assessment Program (MKSAP) 11, 15, 16, 17, 18, 19. American College of Physicians, Philadelphia 1998, 2009, 2012, 2015, 2018, 2021.
  2. Journal Watch 24(11):88-89, 2004 Hsue PY, Lo JC, Franklin A, Bolger AF, Martin JN, Deeks SG, Waters DD. Progression of atherosclerosis as assessed by carotid intima- media thickness in patients with HIV infection. Circulation. 2004 Apr 6;109(13):1603-8. Epub 2004 Mar 15. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15023877
  3. The Data Collection on Adverse Effects of Anti-HIV Drugs Study Group: Liver-related deaths in person effected with the human immunodeficiency virus: The D:A:D study. Arch Intern Med 2006k 166:1632 PMID: https://www.ncbi.nlm.nih.gov/pubmed/16908797
  4. 4.0 4.1 4.2 Geriatric Review Syllabus, 7th edition Parada JT et al (eds) American Geriatrics Society, 2010
    Geriatric Review Syllabus, 11th edition (GRS11) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2022
  5. 5.0 5.1 Smith CJ et al Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. The Lancet, 384(9939):241-248, 19 July 2014 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25042234 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2960604-8/abstract
  6. 6.0 6.1 Shiels MS, Islam JY, Rosenberg PS et al. Projected cancer incidence rates and burden of incident cancer cases in HIV-infected adults in the United States through 2030. Ann Intern Med 2018 May 8 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29801099 <Internet> http://annals.org/aim/article-abstract/2680725/projected-cancer-incidence-rates-burden-incident-cancer-cases-hiv-infected
  7. 7.0 7.1 7.2 Park LS, Tate JP, Sigel K et al Association of Viral Suppression With Lower AIDS-Defining and Non-AIDS-Defining Cancer Incidence in HIV-Infected Veterans: A Prospective Cohort Study. Ann Intern Med. 2018. June 12. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29893768 <Internet> http://annals.org/aim/article-abstract/2684480/association-viral-suppression-lower-aids-defining-non-aids-defining-cancer
  8. 8.0 8.1 8.2 Bosh KA, Johnson AS, Hernandez AL, et al. Vital Signs: Deaths Among Persons with Diagnosed HIV Infection, United States, 2010-2018. MMWR Morb Mortal Wkly Rep 2020;69:1717-1724 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33211683 Free article https://www.cdc.gov/mmwr/volumes/69/wr/mm6946a1.htm
  9. 9.0 9.1 Kooij KW, Wit FW, Schouten J et al. HIV infection is independently associated with frailty in middle-aged HIV type 1- infected individuals compared with similar but uninfected controls. AIDS. 2016;30(2):241-250 PMID: https://www.ncbi.nlm.nih.gov/pubmed/26684821 https://journals.lww.com/aidsonline/Fulltext/2016/01140/HIV_infection_is_independently_associated_with.10.aspx
  10. Fukui SM, Piggott DA, Erlandson KM. Inflammation strikes again: frailty and HIV. Curr HIV/AIDS Rep. 2018;15(1):20-29 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29411315
  11. 11.0 11.1 Lellouche L, Gutierrez LA, Leclercq P et al. Frailty in aging people living with HIV: A matched controlled study. J Acquir Immune Defic Syndr 2021 Jul 6; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34238822 https://journals.lww.com/jaids/Abstract/9000/Frailty_in_Aging_People_Living_With_HIV__a_matched.95850.aspx
  12. NEJM Knowledge+ Hematology
  13. 13.0 13.1 NEJM Knowledge+ Complex Medical Care
  14. 14.0 14.1 DHHS Panel. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: Syphilis. Department of Health and Human Services 2023 Sep 7; [e-pub] https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/whats-new